Regenerative Medicine

Regenyx

HQ Location:

Israel

CEO

Yaron Rapaport

EST.

2019

Lead Product:

Lipogenyx — a matrix-enhanced fat-grafting scaffold / “fat viability extender” built on proprietary synthetic peptide hydrogel technology.

Regenyx Medical is developing regenerative solutions for minimally invasive soft-tissue restoration. Its lead product, Lipogenyx, is designed to improve fat graft survival, integration, and long-term outcomes in reconstructive and aesthetic procedures by combining autologous fat with a proprietary peptide hydrogel scaffold.